Literature DB >> 19864237

Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.

Mylinh T Mac1, Fai Chung, Fan Lin, Pei Hui, Bonnie L Balzer, Hanlin L Wang.   

Abstract

Hepatocyte antigen is recognized by antibody Hep Par 1, a widely used diagnostic immunomarker for hepatocellular carcinoma and tumors with hepatoid differentiation. Hepatocyte antigen expression has also been detected in nonneoplastic small intestinal epithelium, but expression in small intestinal adenocarcinoma has not been well investigated. We immunohistochemically examined 39 nonampullary small intestinal adenocarcinomas for hepatocyte antigen expression; 34 cases contained normal-appearing nonneoplastic small intestinal mucosa on the same tissue sections. In 30 cases (88%), the nonneoplastic mucosa exhibited granular cytoplasmic Hep Par 1 staining exclusively in the epithelium. Only 9 small intestinal adenocarcinomas (23%) showed focal positive cytoplasmic staining. Nonneoplastic colonic epithelium was negative for Hep Par 1. In 31 colorectal adenocarcinomas, 3 (10%) showed positive staining for Hep Par 1 (1 diffuse, 2 focal), a frequency not different from that for small intestinal adenocarcinomas (P = .2467). Tumors expressing hepatocyte antigen did not exhibit evidence of hepatoid differentiation and were histologically indistinguishable from hepatocyte antigen-negative tumors. Hepatocyte antigen immunoreactivity is selectively expressed in nonneoplastic small intestinal enterocytes but not in colonocytes, suggesting a potential physiologic role in intestinal biology. Whether the loss of antigen expression in a large number of small intestinal adenocarcinomas serves a role in small intestinal tumorigenesis remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864237     DOI: 10.1309/AJCPUD0P5NQBOYPK

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Role of Hepatocyte Paraffin 1 antigen in the course of colorectal carcinogenesis.

Authors:  Riham M Abu-Zeid; Rola M Farid
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

2.  Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.

Authors:  Yi-Ying Lee; Chien-Feng Li; Ching-Yih Lin; Sung-Wei Lee; Ming-Jen Sheu; Li-Ching Lin; Tzu-Ju Chen; Ting-Feng Wu; Chung-Hsi Hsing
Journal:  Tumour Biol       Date:  2014-08-07

3.  Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.

Authors:  Qing-Long Li; Zhu-Lin Yang; Jie-Qiong Liu; Xiong-Ying Miao
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

Review 4.  Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.

Authors:  Yoshihisa Takahashi; Erdenetsogt Dungubat; Hiroyuki Kusano; Dariimaa Ganbat; Yasuhiko Tomita; Sarandelger Odgerel; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.